FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

FDA Struggles to Recruit in Wake of Retirements

FDA chief of staff Julie Tierney says the agency is experiencing a larger-than-normal exodus of retiring employees now that the Covid-19 public health...

latest-news-card-1
Medical Devices

Abiomed Recalls Impella Heart Pump

Abiomed recalls its Impella 5.5 with SmartAssist System after receiving complaints about purge fluid leaking from the devices purge sidearm.

latest-news-card-1
Medical Devices

FDA on Pneumatic Tourniquet Cuff Shortage

FDA issues a Dear Doctor letter about supply constraints involving non-sterile, single-use pneumatic tourniquet cuffs in the U.S.

latest-news-card-1
Human Drugs

FDA Lifts Hold on Foghorn Leukemia Drug

FDA removes a partial clinical hold against Foghorn Therapeutics Phase 1 monotherapy dose escalation study of FHD-286 in acute myelogenous leukemia an...

latest-news-card-1
Medical Devices

Draeger Recalls Ventilator Sets/Tubing

Draeger Medical recalls its ventilator set, tubing and support (with harness) because glued connections on the breathing circuit can become loose.

latest-news-card-1
Human Drugs

Intas Pharma on Import Alert After Inspection

FDA places an import alert on drug products manufactured by Intas Pharmaceuticals in Ahmedabad, Gujarat, India due to significant GMP violations docum...

latest-news-card-1
Human Drugs

FDA Extends Review of SpringWorks NDA

FDA extends by three months its review of a SpringWorks Therapeutics NDA for nirogacestat for treating adults with desmoid tumors.

latest-news-card-1
Human Drugs

Guidance on ANDA Cover Letter Attachments

FDA posts a final guidance entitled Cover Letter Attachments for Controlled Correspondence and ANDA Submissions.

latest-news-card-1
Federal Register

Guide on Nonclinical Immunotoxic Evaluations

FDA posts a final guidance entitled Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals.

latest-news-card-1
Federal Register

Therapeutic Protein Drug-Drug Interactions Guide

Federal Register notice: FDA makes available a final guidance entitled Drug-Drug Interaction (DDI) Assessment for Therapeutic Proteins.